The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, September 18, 2020
Boehringer Ingelheim announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrate BI 425809 met its primary endpoint.
read more
Friday, September 18, 2020
Fortress announced Caelum, in collaboration with Alexion, has initiated the CARES program to evaluate CAEL-101 in combination with standard-of-care (...
read more
Thursday, September 17, 2020
REYVOW for migraine had 3.8 and 4.6 times greater odds, respectively, of achieving pain freedom at 2 hours compared to those taking placebo.
read more
Wednesday, September 16, 2020
NeuroSense announced PrimeC was safe and well tolerated in the interim analysis of study NST002, a Phase IIa study.
read more
Wednesday, September 16, 2020
AXON Neuroscience announced positive pre-clinical results for ACvac1, its vaccine candidate against novel coronavirus SARS-CoV-2.
read more
Wednesday, September 16, 2020
AstraZeneca Pharmaceuticals
Fasenra compared with placebo demonstrated a statistically significant improvement in the size of nasal polyps and in nasal blockage in patients with ...
read more
Tuesday, September 15, 2020
AstraZeneca Pharmaceuticals
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the MHRA that it was safe to...
read more
Tuesday, September 15, 2020
Pfizer and BioNTech have submitted an amended protocol to the FDA to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial.
read more
Tuesday, September 15, 2020
AZTherapies announced the dosing of the first patient in its Phase 2a clinical trial examining the safety and efficacy of ALZT-OP1a in patients with ...
read more
Monday, September 14, 2020
The LLS is launching the first clinical trial for blood cancer patients at risk of death if infected with the COVID-19 virus.
read more
Monday, September 14, 2020
MyoKardia announced the first patient has been dosed in the company’s trial of danicamtiv for primary dilated cardiomyopathy.
read more
Monday, September 14, 2020
Direct Biologics announced the launch of their trial examining the use of ExoFlo extracellular vesicles to treat COVID-19 ARDS.
read more
Friday, September 11, 2020
Eveliqure announced the award of a US government contract from the NIAID with the intent to fund the development of its vaccine candidate, ShigETEC.
read more
Friday, September 11, 2020
Intra-Cellular Therapies announced positive topline results from its trial evaluating lumateperone as adjunctive therapy to lithium or valproate for ...
read more
Friday, September 11, 2020
Viking announced the initiation of a Phase 1 SAD and MAD clinical trial of VK0214, a novel, orally available TRß agonist as a potential treatment for ...
read more